• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Generic Injectables Market

    ID: MRFR/HC/11480-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Generic Injectables Market Infographic
    Purchase Options

    US Generic Injectables Market Summary

    The US Generic Injectables market is projected to experience substantial growth from 235.94 USD Billion in 2024 to 541.32 USD Billion by 2035.

    Key Market Trends & Highlights

    US Generic Injectables Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 7.84% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 541.32 USD Billion, indicating robust expansion.
    • In 2024, the market is valued at 235.94 USD Billion, reflecting a strong foundation for future growth.
    • Growing adoption of generic injectables due to cost-effectiveness is a major market driver.

    Market Size & Forecast

    2024 Market Size 235.94 (USD Billion)
    2035 Market Size 541.32 (USD Billion)
    CAGR (2025 - 2035) 7.84%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Generic Injectables Market market include

    Report Scope

    Report Attribute/Metric Details
    Market Size 2022 USD 79.5 billion
    Market Size 2023 USD 83.6 billion
    Market Size 2032 USD 124.59 Billion
    Compound Annual Growth Rate (CAGR)  5.1% (2023-2030)
    Base Year 2022
    Market Forecast Period 2023-2032
    Historical Data 2018 - 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Material, Type, Design, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled SCHOTT AG, BD, Gerresheimer AG, West Pharmaceutical Services Inc, AptarGroup Inc., Helvoet Rubber & Plastic Technologies B.V., Terumo Corporation, Nipro PharmaPackaging International Company.
    Key Market Opportunities spending on health will get a huge boost
    Key Market Dynamics Rising Demand for self-injection and related devices Rising numbers, incidence and prevalence of various chronic diseases

    FAQs

    What is the projected market size of the US Generic Injectables Market in 2024?

    The US Generic Injectables Market is projected to be valued at 10.57 billion USD in 2024.

    What will the market size of the US Generic Injectables Market be by 2035?

    By 2035, the US Generic Injectables Market is expected to reach a value of 18.0 billion USD.

    What is the expected CAGR for the US Generic Injectables Market from 2025 to 2035?

    The market is expected to experience a compound annual growth rate (CAGR) of 4.959% from 2025 to 2035.

    Which formulation type holds the largest market share in the US Generic Injectables Market in 2024?

    In 2024, the solution formulation type holds the largest market share valued at 4.5 billion USD.

    What are the projected market values of the suspension formulation type by 2035?

    The suspension formulation type is projected to be valued at 4.0 billion USD by 2035.

    Who are the key players in the US Generic Injectables Market?

    Major players include Zydus Cadila, Accord Healthcare, Apotex, Sandoz, and Baxter International.

    What will the market size be for the emulsion formulation type in 2035?

    The emulsion formulation type is expected to be valued at 3.0 billion USD by 2035.

    What challenges does the US Generic Injectables Market currently face?

    The market faces challenges such as regulatory hurdles and market saturation among generic products.

    What growth opportunities exist in the US Generic Injectables Market?

    There are opportunities in expanding production capabilities and increasing the range of therapeutic areas served.

    What is the value projection for the lyophilized formulation type in 2035?

    The lyophilized formulation type is expected to grow to a value of 3.5 billion USD by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials